Biomedical Engineering Reference
In-Depth Information
59. EMEA (1995) ICH Topic Q 2 (R1) Validation of analytical procedures: text and methodology.
http://www.emea.eu.int
60. Peters FT, Drummer OH, Musshoff F (2007) Validation of new methods. Forensic Sci Int
165(2-3):216-224. doi:
S0379-0738(06)00323-9 [pii] 10.1016/j.forsciint.2006.05.021
61. Maurer HH (2007) Current role of liquid chromatography-mass spectrometry in clinical and
forensic toxicology. Anal Bioanal Chem 388(7):1315-1325. doi
:
10.1007/s00216-007-1248-5
62. Marchi I, Rudaz S, Veuthey JL (2009) Sample preparation development and matrix effects
evaluation for multianalyte determination in urine. J Pharm Biomed Anal 49(2):459-467.
doi:
S0731-7085(08)00639-0 [pii] 10.1016/j.jpba.2008.11.040
63. Dams R, Huestis MA, Lambert WE, Murphy CM (2003) Matrix effect in bio-analysis of illicit
drugs with LC-MS/MS: influence of ionization type, sample preparation, and biofluid. J Am
Soc Mass Spectrom 14(11):1290-1294. doi:
S1044030503005749 [pii]
64. Matuszewski BK, Constanzer ML, Chavez-Eng CM (2003) Strategies for the assessment of
matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem
75(13):3019-3030
65. Bonfiglio R, King RC, Olah TV, Merkle K (1999) The effects of sample preparation methods on
the variability of the electrospray ionization response for model drug compounds. Rapid Commun
Mass Spectrom 13(12):1175-1185. doi:10.1002/(SICI)1097-0231(19990630)13:12<1175::AID-
RCM639>3.0.CO;2-0 [pii] 10.1002/(SICI)1097-0231(19990630)13:12<1175::AID-RCM639>
3.0.CO;2-0
66. Sergi M, Compagnone D, Curini R, D'Ascenzo G, Del Carlo M, Napoletano S, Risoluti R
(2010) Micro-solid phase extraction coupled with high-performance liquid chromatography-
tandem mass spectrometry for the determination of stimulants, hallucinogens, ketamine and
phencyclidine in oral fluids. Anal Chim Acta 675(2):132-137. doi
:
10.1016/j.aca.2010.07.011
67. Napoletano S, Montesano C, Compagnone D, Curini R, D'Ascenzo G, Roccia C, Sergi M
(2011) Determination of illicit drugs in urine and plasma by micro-SPE followed by HPLC-MS/
MS. Chromatographia. doi:
10.1007/s10337-011-2156-6
68. ISO/IEC (2005) ISO/IEC 17025:2005. Incorporating Corrigendum no. 1. Published under the
authority of the Standards Policy and Strategy Committee on 29 June 2005.
69. Drolc A, Cotman M, Ros M (2005) Integration of metrological principles in a proficiency-
testing scheme in the field of water analysis. Anal Bioanal Chem 382(5):1311-1319.
doi:
10.1007/s00216-005-3264-7
70. Maralikova B, Weinmann W (2004) Confirmatory analysis for drugs of abuse in plasma and
urine by high-performance liquid chromatography-tandem mass spectrometry with respect to
criteria for compound identification. J Chromatogr B Analyt Technol Biomed Life Sci
811(1):21-30. doi:
10.1016/j.jchromb.2004.04.039 S1570-0232(04)00642-7 [pii]
71. Sauvage FL, Gaulier JM, Lachatre G, Marquet P (2008) Pitfalls and prevention strategies for
liquid chromatography-tandem mass spectrometry in the selected reaction-monitoring mode
for drug analysis. Clin Chem 54(9):1519-1527. doi:
clinchem.2008.105478 [pii] 10.1373/
72. Arpino PJ (1982) On-line liquid chromatography/mass spectrometry? An odd couple! Trends
Anal Chem 1(7):154-158. doi:
10.1016/0165-9936(82)80049-6
73. Polettini A (2006) Applications of LC-MS in toxicology. Pharmaceutical Press, London
74. Watson JT, Sparkman OD (2007) Introduction to mass spectrometry: instrumentation, applica-
tions and strategies for data interpretation, 4th edn. Wiley-Blackwell, Chichester
75. Gallagher RT, Balogh MP, Davey P, Jackson MR, Sinclair I, Southern LJ (2003) Combined
electrospray ionization-atmospheric pressure chemical ionization source for use in high-
throughput LC-MS applications. Anal Chem 75(4):973-977
76. Chena BH, Liu JT, Chena WX, Chena HM, CH L (2008) A general approach to the screening
and confirmation of tryptamines and phenethylamines by mass spectral fragmentation. Talanta
74:512-517
77. Wang PP, Bartlett MG (1998) Collision-induced dissociation mass spectra of cocaine, and its
metabolites and pyrolysis products. J Mass Spectrom 33:961-967
78. Al-Sayah MA, Rizos P, Antonucci V, Wu N (2008) High throughput screening of active phar-
maceutical ingredients by UPLC. J Sep Sci 31(12):2167-2172. doi:
10.1002/jssc.200700594
